{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:41:23Z","timestamp":1793781683952,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010327","name":"Stichting Glaucoomfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010321","name":"Oogfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010328","name":"Stichting Lijf en Leven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henkes stichting"},{"DOI":"10.13039\/501100010331","name":"Stichting voor Ooglijders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010374","name":"Stichting Blindenhulp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003061","name":"Erasmus Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001828","name":"Erasmus Universiteit Rotterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Research Institute for Diseases in the Elderly"},{"DOI":"10.13039\/501100003245","name":"Ministerie van Onderwijs, Cultuur en Wetenschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004431","name":"Directorate-General for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Municipality of Rotterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Testosterone may be a possible modifiable risk factor for open-angle glaucoma (OAG) and intraocular pressure (IOP), but evidence has been scarce and conflicting. In this study we evaluated the association of testosterone and its genetic predisposition with incident (i) OAG, IOP, retinal nerve fiber layer (RNFL), and ganglion cell-inner plexiform layer (GCL\u2009+).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants aged 45\u2013100\u00a0years were derived from the prospective, population-based Rotterdam Study. Ophthalmic examinations and serum testosterone measurements (including bioavailable and free testosterone) were performed from 1991 onwards. Follow-up took place every 4\u20135\u00a0years. A total of 187 out of 7898 participants were diagnosed with incident (i) OAG during follow-up. Genotyping was performed in 165 glaucoma cases and 6708 controls. We calculated sex-specific weighted genetic risk scores (GRS) for total and bioavailable testosterone. Associations with iOAG were analyzed using multivariable logistic regression. Associations with IOP, RNFL, and GCL\u2009+\u2009were analyzed with multivariable linear regression. Analyses were stratified on sex and adjusted for at least age, body mass index, and follow-up duration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In men, testosterone was not associated with iOAG. However, the GRS for higher total testosterone was associated with an increased iOAG risk (odds ratio [OR] with 95% confidence interval [95% CI]: 2.48 [1.18; 5.22], per unit). In women, higher values of bioavailable testosterone (2.05 [1.00; 4.18] per nmol\/L) and free testosterone (1.79 [1.00; 3.20] per ng\/dL) were significantly associated with increased risk of iOAG. Moreover, the GRS for higher bioavailable testosterone was associated with an increased iOAG risk (2.48 [1.09; 5.65], per unit). Higher bioavailable and free testosterone were adversely associated with IOP (0.58 [0.05; 1.10] per nmol\/L and 0.47 [0.04; 0.90] per ng\/dL). Higher total testosterone was inversely associated with peripapillary RNFL and GCL\u2009+\u2009(Beta [95% CI]: \u2212 3.54 [\u2212 7.02; \u2212 0.06] per nmol\/L and \u2212 2.18 [\u2212 4.11; \u2212 0.25] per nmol\/L, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In women, higher testosterone levels increased the risk of iOAG. Both IOP-dependent and IOP-independent mechanisms may underlie this association. Managing testosterone levels may be particularly relevant for the prevention of neurodegeneration in the eye. Future research should confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13293-023-00512-z","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T04:27:32Z","timestamp":1683692852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Higher testosterone is associated with open-angle glaucoma in women: a genetic predisposition?"],"prefix":"10.1186","volume":"14","author":[{"given":"Jo\u00eblle E.","family":"Vergroesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Kaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Aribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce B. J.","family":"van Meurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C. W.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-5281","authenticated-orcid":false,"given":"Wishal D.","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"3","key":"512_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"512_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901\u201311.","journal-title":"JAMA"},{"issue":"12","key":"512_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/IJG.0000000000001106","volume":"27","author":"P Patel","year":"2018","unstructured":"Patel P, Harris A, Toris C, Tobe L, Lang M, Belamkar A, et al. Effects of sex hormones on ocular blood flow and intraocular pressure in primary open-angle glaucoma: a review. J Glaucoma. 2018;27(12):1037\u201341.","journal-title":"J Glaucoma"},{"issue":"6","key":"512_CR4","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.3390\/ijms23063269","volume":"23","author":"R Nuzzi","year":"2022","unstructured":"Nuzzi R, Caselgrandi P. Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience. Int J Mol Sci. 2022;23(6):3269.","journal-title":"Int J Mol Sci"},{"issue":"Pt 6","key":"512_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1258\/acb.2010.010150","volume":"47","author":"PE Belchetz","year":"2010","unstructured":"Belchetz PE, Barth JH, Kaufman JM. Biochemical endocrinology of the hypogonadal male. Ann Clin Biochem. 2010;47(Pt 6):503\u201315.","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"512_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1210\/er.2018-00020","volume":"39","author":"DJ Handelsman","year":"2018","unstructured":"Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 2018;39(5):803\u201329.","journal-title":"Endocr Rev"},{"issue":"4","key":"512_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.31887\/DCNS.2016.18.4\/fmauvais","volume":"18","author":"J Morford","year":"2016","unstructured":"Morford J, Mauvais-Jarvis F. Sex differences in the effects of androgens acting in the central nervous system on metabolism. Dialogues Clin Neurosci. 2016;18(4):415\u201324.","journal-title":"Dialogues Clin Neurosci"},{"key":"512_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2022.06.003","author":"KM Madjedi","year":"2022","unstructured":"Madjedi KM, Stuart KV, Chua SYL, Foster PJ, Strouthidis NG, Luben RN, et al. The association of female reproductive factors with glaucoma and related traits: a systematic review. Ophthalmol Glaucoma. 2022. https:\/\/doi.org\/10.1016\/j.ogla.2022.06.003.","journal-title":"Ophthalmol Glaucoma."},{"issue":"1\u20132","key":"512_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/08820538.2015.1114845","volume":"31","author":"SS Dewundara","year":"2016","unstructured":"Dewundara SS, Wiggs JL, Sullivan DA, Pasquale LR. Is estrogen a therapeutic target for glaucoma? Seminars in Ophthalmology. 2016;31(1\u20132):140\u20136.","journal-title":"Seminars in Ophthalmology"},{"key":"512_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01179-z","author":"A Douglass","year":"2022","unstructured":"Douglass A, Dattilo M, Feola AJ. Evidence for menopause as a sex-specific risk factor for glaucoma. Cell Mol Neurobiol. 2022. https:\/\/doi.org\/10.1007\/s10571-021-01179-z.","journal-title":"Cell Mol Neurobiol"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10571-020-00965-5","volume":"42","author":"K Fotesko","year":"2022","unstructured":"Fotesko K, Thomsen B, Kolko M, Vohra R. Girl power in glaucoma: the role of estrogen in primary open angle glaucoma. Cell Mol Neurobiol. 2022;42:1\u201317.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"512_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/aje\/154.2.138","volume":"154","author":"CA Hulsman","year":"2001","unstructured":"Hulsman CA, Westendorp IC, Ramrattan RS, Wolfs RC, Witteman JC, Vingerling JR, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol. 2001;154(2):138\u201344.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"512_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","volume":"32","author":"MA Ikram","year":"2017","unstructured":"Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32(9):807\u201350.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"512_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamaneurol.2018.1563","volume":"75","author":"U Mutlu","year":"2018","unstructured":"Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ, et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol. 2018;75(10):1256\u201363.","journal-title":"JAMA Neurol"},{"issue":"4","key":"512_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10384-013-0239-7","volume":"57","author":"KE Kim","year":"2013","unstructured":"Kim KE, Ahn SJ, Kim DM. Comparison of two different spectral domain optical coherence tomography devices in the detection of localized retinal nerve fiber layer defects. Jpn J Ophthalmol. 2013;57(4):347\u201358.","journal-title":"Jpn J Ophthalmol"},{"key":"512_CR16","doi-asserted-by":"crossref","unstructured":"Tan O, Li G, Lu AT, Varma R, Huang D, Advanced Imaging for Glaucoma Study G. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology. 2008;115(6):949\u201356.","DOI":"10.1016\/j.ophtha.2007.08.011"},{"issue":"4","key":"512_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153830","volume":"11","author":"LP Cunha","year":"2016","unstructured":"Cunha LP, Lopes LC, Costa-Cunha LV, Costa CF, Pires LA, Almeida AL, et al. Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer\u2019s disease. PLoS ONE. 2016;11(4): e0153830.","journal-title":"PLoS ONE"},{"issue":"8","key":"512_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10654-017-0270-y","volume":"32","author":"H Springelkamp","year":"2017","unstructured":"Springelkamp H, Wolfs RC, Ramdas WD, Hofman A, Vingerling JR, Klaver CC, et al. Incidence of glaucomatous visual field loss after two decades of follow-up: the Rotterdam Study. Eur J Epidemiol. 2017;32(8):691\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"512_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ajhg.2007.10.003","volume":"82","author":"M Kayser","year":"2008","unstructured":"Kayser M, Liu F, Janssens AC, Rivadeneira F, Lao O, van Duijn K, et al. Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. Am J Hum Genet. 2008;82(2):411\u201323.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"512_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","volume":"35","author":"MA Ikram","year":"2020","unstructured":"Ikram MA, Brusselle G, Ghanbari M, Goedegebure A, Ikram MK, Kavousi M, et al. Objectives, design and main findings until 2020 from the Rotterdam Study. Eur J Epidemiol. 2020;35(5):483\u2013517.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"512_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"512_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00125-016-4136-8","volume":"60","author":"A Brahimaj","year":"2017","unstructured":"Brahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study. Diabetologia. 2017;60(1):98\u2013106.","journal-title":"Diabetologia"},{"issue":"1","key":"512_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jlb\/lsx004","volume":"4","author":"M Sudai","year":"2017","unstructured":"Sudai M. The testosterone rule-constructing fairness in professional sport. J Law Biosci. 2017;4(1):181\u201393.","journal-title":"J Law Biosci"},{"issue":"10","key":"512_CR24","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"512_CR25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/oxfordjournals.aje.a115821","volume":"133","author":"CJ Caspersen","year":"1991","unstructured":"Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 1991;133(11):1078\u201392.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"512_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jclinepi.2003.07.008","volume":"57","author":"VS Stel","year":"2004","unstructured":"Stel VS, Smit JH, Pluijm SM, Visser M, Deeg DJ, Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol. 2004;57(3):252\u20138.","journal-title":"J Clin Epidemiol"},{"key":"512_CR27","unstructured":"ATC\/DDD Index 2022: World Health Organization (WHO); https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 14 Dec 2021."},{"issue":"7","key":"512_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","volume":"140","author":"JE Vergroesen","year":"2022","unstructured":"Vergroesen JE, Thee EF, Ahmadizar F, van Duijn CM, Stricker BH, Kavousi M, et al. Association of diabetes medication with open-angle glaucoma, age-related macular degeneration, and cataract in the Rotterdam study. JAMA Ophthalmology. 2022;140(7):674\u201381.","journal-title":"JAMA Ophthalmology"},{"issue":"12","key":"512_CR29","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1161\/ATVBAHA.111.234948","volume":"31","author":"RG Wieberdink","year":"2011","unstructured":"Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"512_CR30","first-page":"153","volume":"22","author":"S Hiller-Sturmh\u00f6fel","year":"1998","unstructured":"Hiller-Sturmh\u00f6fel S, Bartke A. The endocrine system: an overview. Alcohol Health Res World. 1998;22(3):153\u201364.","journal-title":"Alcohol Health Res World"},{"key":"512_CR31","unstructured":"Panchami, Pai SR, Shenoy JP, Kole SB. Postmenopausal intraocular pressure changes in South Indian females. J Clin Diagn Res. 2013;7(7):1322\u20134."},{"issue":"5","key":"512_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.61.5.16","volume":"61","author":"AJ Feola","year":"2020","unstructured":"Feola AJ, Sherwood JM, Pardue MT, Overby DR, Ethier CR. Age and menopause effects on ocular compliance and aqueous outflow. Invest Ophthalmol Vis Sci. 2020;61(5):16.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"512_CR33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2011-3362","volume":"97","author":"SD Harlow","year":"2012","unstructured":"Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159\u201368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"512_CR34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1172\/JCI125755","volume":"129","author":"SR Hammes","year":"2019","unstructured":"Hammes SR, Levin ER. Impact of estrogens in males and androgens in females. J Clin Invest. 2019;129(5):1818\u201326.","journal-title":"J Clin Invest"},{"issue":"4","key":"512_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13685530601060396","volume":"9","author":"FM K\u00f6hn","year":"2006","unstructured":"K\u00f6hn FM. Testosterone and body functions. Aging Male. 2006;9(4):183\u20138.","journal-title":"Aging Male"},{"issue":"11","key":"512_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/gerona\/gls068","volume":"67","author":"AM Horstman","year":"2012","unstructured":"Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci. 2012;67(11):1140\u201352.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"512_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"512_CR38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1210\/jcem-61-4-705","volume":"61","author":"A Manni","year":"1985","unstructured":"Manni A, Pardridge WM, Cefalu W, Nisula BC, Bardin CW, Santner SJ, et al. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab. 1985;61(4):705\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"512_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","volume":"3","author":"DC Anderson","year":"1974","unstructured":"Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol (Oxf). 1974;3(1):69\u201396.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"512_CR40","doi-asserted-by":"crossref","unstructured":"Diver MJ, Clinical Science Reviews Committee of the Association for Clinical B. Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men. Ann Clin Biochem. 2006;43(Pt 1):3\u201312.","DOI":"10.1258\/000456306775141803"},{"issue":"4","key":"512_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2017-00025","volume":"38","author":"AL Goldman","year":"2017","unstructured":"Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone\u2019s Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. 2017;38(4):302\u201324.","journal-title":"Endocr Rev"},{"issue":"10","key":"512_CR42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/GME.0000000000001120","volume":"25","author":"JH Kang","year":"2018","unstructured":"Kang JH, Rosner BA, Wiggs JL, Pasquale LR. Sex hormone levels and risk of primary open-angle glaucoma in postmenopausal women. Menopause. 2018;25(10):1116\u201323.","journal-title":"Menopause"},{"issue":"4","key":"512_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.prnil.2021.05.001","volume":"9","author":"HK Ahn","year":"2021","unstructured":"Ahn HK, Lee HS, Park JY, Kim DK, Kim M, Hwang HS, et al. Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study. Prostate Int. 2021;9(4):197\u2013202.","journal-title":"Prostate Int"},{"issue":"1","key":"512_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eururo.2020.06.002","volume":"79","author":"M Abufaraj","year":"2021","unstructured":"Abufaraj M, Iwata T, Kimura S, Haddad A, Al-Ani H, Abusubaih L, et al. Differential impact of gonadotropin-releasing hormone antagonist versus agonist on clinical safety and oncologic outcomes on patients with metastatic prostate cancer: a meta-analysis of randomized controlled trials. Eur Urol. 2021;79(1):44\u201353.","journal-title":"Eur Urol"},{"issue":"4","key":"512_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/00325481.2015.1033376","volume":"127","author":"G Gokce","year":"2015","unstructured":"Gokce G, Hurmeric V, Mumcuoglu T, Ozge G, Basaran Y, Unal HU, et al. Effects of androgen replacement therapy on cornea and tear function in men with idiopathic hypogonadotropic hypogonadism. Postgrad Med. 2015;127(4):376\u201380.","journal-title":"Postgrad Med"},{"issue":"4","key":"512_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.5534\/wjmh.200066","volume":"39","author":"JS Lee","year":"2021","unstructured":"Lee JS, Lee MH, Kim JH, Jo YJ, Shin JH, Park HJ. Cross sectional study among intraocular pressure, mean arterial blood pressure, and serum testosterone according to the anthropometric obesity indices in Korean men. World J Mens Health. 2021;39(4):697\u2013704.","journal-title":"World J Mens Health"},{"issue":"5","key":"512_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00061198-200310000-00007","volume":"12","author":"E Toker","year":"2003","unstructured":"Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma. 2003;12(5):436\u201340.","journal-title":"J Glaucoma"},{"issue":"1","key":"512_CR48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/gme.0b013e3181aa2734","volume":"17","author":"HG Yu","year":"2010","unstructured":"Yu HG, Ku SY, Choi J, Kim H, Suh CS, Kim SH, et al. Sex steroid and tropic hormone levels may be associated with postoperative prognosis of vitrectomy in Korean postmenopausal women: a pilot study. Menopause. 2010;17(1):161\u20135.","journal-title":"Menopause"},{"issue":"8","key":"512_CR49","first-page":"2832","volume":"85","author":"HG Burger","year":"2000","unstructured":"Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85(8):2832\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"512_CR50","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"512_CR51","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1210\/jc.2007-0581","volume":"92","author":"RH Fogle","year":"2007","unstructured":"Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92(8):3040\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"512_CR52","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s10792-021-01921-y","volume":"41","author":"O Alpogan","year":"2021","unstructured":"Alpogan O, Donmez EE, Bal\u0131k A, Vural F, Kaplan G. Effects of testosterone on intraocular pressure, thicknesses of retinal nerve fiber layer, ganglion cell complex, macula and on ocular blood flow in female-to-male transgender persons. Int Ophthalmol. 2021;41(11):3651\u201361.","journal-title":"Int Ophthalmol"},{"key":"512_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/193078","volume":"2015","author":"JE de Souza-J\u00fanior","year":"2015","unstructured":"de Souza-J\u00fanior JE, Garcia CA, Soares EM, Maranh\u00e3o TM, Lemos TM, Azevedo GD. Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol. 2015;2015: 193078.","journal-title":"J Ophthalmol"},{"issue":"6","key":"512_CR54","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1210\/jc.2009-2575","volume":"95","author":"MM Fern\u00e1ndez-Balsells","year":"2010","unstructured":"Fern\u00e1ndez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95(6):2560\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"512_CR55","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1210\/jc.2014-2260","volume":"99","author":"ME Wierman","year":"2014","unstructured":"Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489\u2013510.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"512_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000119417","volume":"31","author":"T Kienitz","year":"2008","unstructured":"Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res. 2008;31(2):71\u20139.","journal-title":"Kidney Blood Press Res"},{"key":"512_CR57","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/CIA.S195498","volume":"14","author":"N Li","year":"2019","unstructured":"Li N, Ma R, Wang S, Zhao Y, Wang P, Yang Z, et al. The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women. Clin Interv Aging. 2019;14:743\u201352.","journal-title":"Clin Interv Aging"},{"issue":"3","key":"512_CR58","first-page":"693","volume":"16","author":"HW Huisman","year":"2006","unstructured":"Huisman HW, Schutte AE, Van Rooyen JM, Malan NT, Malan L, Schutte R, et al. The influence of testosterone on blood pressure and risk factors for cardiovascular disease in a black South African population. Ethn Dis. 2006;16(3):693\u20138.","journal-title":"Ethn Dis"},{"issue":"1","key":"512_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5534\/wjmh.180027","volume":"37","author":"G Hackett","year":"2019","unstructured":"Hackett G. Type 2 diabetes and testosterone therapy. World J Mens Health. 2019;37(1):31\u201344.","journal-title":"World J Mens Health"},{"key":"512_CR60","first-page":"481","volume":"7","author":"AM Beatrice","year":"2014","unstructured":"Beatrice AM, Dutta D, Kumar M, Kumbenahalli Siddegowda S, Sinha A, Ray S, et al. Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications. Diabetes Metab Syndr Obes. 2014;7:481\u20136.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"512_CR61","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jdi.12288","volume":"6","author":"KK Cheung","year":"2015","unstructured":"Cheung KK, Luk AO, So WY, Ma RC, Kong AP, Chow FC, et al. Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: a review of current evidence. J Diabetes Investig. 2015;6(2):112\u201323.","journal-title":"J Diabetes Investig"},{"issue":"7","key":"512_CR62","volume":"13","author":"N Kumari","year":"2021","unstructured":"Kumari N, Khan A, Shaikh U, Lobes K, Kumar D, Suman F, et al. Comparison of testosterone levels in patients with and without type 2 diabetes. Cureus. 2021;13(7): e16288.","journal-title":"Cureus"},{"issue":"1","key":"512_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1530\/EC-17-0253","volume":"7","author":"QM Yao","year":"2018","unstructured":"Yao QM, Wang B, An XF, Zhang JA, Ding L. Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis. Endocr Connect. 2018;7(1):220\u201331.","journal-title":"Endocr Connect"},{"issue":"2","key":"512_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MED.0b013e32835edb71","volume":"20","author":"AK Monroe","year":"2013","unstructured":"Monroe AK, Dobs AS. The effect of androgens on lipids. Curr Opin Endocrinol Diabetes Obes. 2013;20(2):132\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"512_CR65","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ijcp.12319","volume":"68","author":"AM Traish","year":"2014","unstructured":"Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2014;68(3):314\u201329.","journal-title":"Int J Clin Pract"},{"key":"512_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1747-597X-7-12","volume":"7","author":"N G\u00e5revik","year":"2012","unstructured":"G\u00e5revik N, Skogastierna C, Rane A, Ekstr\u00f6m L. Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase. Subst Abuse Treat Prev Policy. 2012;7:12.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1\u20132","key":"512_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cca.2007.07.013","volume":"386","author":"V Moal","year":"2007","unstructured":"Moal V, Mathieu E, Reynier P, Malthi\u00e8ry Y, Gallois Y. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta. 2007;386(1\u20132):12\u20139.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"512_CR68","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40618-020-01251-3","volume":"43","author":"S D'Andrea","year":"2020","unstructured":"D\u2019Andrea S, Spaggiari G, Barbonetti A, Santi D. Endogenous transient doping: physical exercise acutely increases testosterone levels-results from a meta-analysis. J Endocrinol Invest. 2020;43(10):1349\u201371.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"512_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1530\/EC-17-0082","volume":"6","author":"LD Hayes","year":"2017","unstructured":"Hayes LD, Herbert P, Sculthorpe NF, Grace FM. Exercise training improves free testosterone in lifelong sedentary aging men. Endocr Connect. 2017;6(5):306\u201310.","journal-title":"Endocr Connect"},{"issue":"1","key":"512_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3164\/jcbn.15-48","volume":"58","author":"H Kumagai","year":"2016","unstructured":"Kumagai H, Zempo-Miyaki A, Yoshikawa T, Tsujimoto T, Tanaka K, Maeda S. Increased physical activity has a greater effect than reduced energy intake on lifestyle modification-induced increases in testosterone. J Clin Biochem Nutr. 2016;58(1):84\u20139.","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"512_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12958-018-0378-2","volume":"16","author":"L Chen","year":"2018","unstructured":"Chen L, Xie YM, Pei JH, Kuang J, Chen HM, Chen Z, et al. Sugar-sweetened beverage intake and serum testosterone levels in adult males 20\u201339 years old in the United States. Reprod Biol Endocrinol. 2018;16(1):61.","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"512_CR72","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/nu10111786","volume":"10","author":"TY Hu","year":"2018","unstructured":"Hu TY, Chen YC, Lin P, Shih CK, Bai CH, Yuan KC, et al. Testosterone-associated dietary pattern predicts low testosterone levels and hypogonadism. Nutrients. 2018;10(11):1786.","journal-title":"Nutrients"},{"issue":"3","key":"512_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2605.2006.00720.x","volume":"30","author":"J Svartberg","year":"2007","unstructured":"Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Troms\u00f8 study. Int J Androl. 2007;30(3):137\u201343.","journal-title":"Int J Androl"},{"issue":"4","key":"512_CR74","doi-asserted-by":"publisher","first-page":"567","DOI":"10.14310\/horm.2002.1445","volume":"12","author":"W Wang","year":"2013","unstructured":"Wang W, Yang X, Liang J, Liao M, Zhang H, Qin X, et al. Cigarette smoking has a positive and independent effect on testosterone levels. Hormones (Athens). 2013;12(4):567\u201377.","journal-title":"Hormones (Athens)"},{"key":"512_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ypmed.2015.12.021","volume":"85","author":"J Zhao","year":"2016","unstructured":"Zhao J, Leung JYY, Lin SL, Mary SC. Cigarette smoking and testosterone in men and women: a systematic review and meta-analysis of observational studies. Prev Med. 2016;85:1\u201310.","journal-title":"Prev Med"},{"issue":"1","key":"512_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0970-1591.124197","volume":"30","author":"EC Osterberg","year":"2014","unstructured":"Osterberg EC, Bernie AM, Ramasamy R. Risks of testosterone replacement therapy in men. Indian J Urol. 2014;30(1):2\u20137.","journal-title":"Indian J Urol"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00512-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-023-00512-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00512-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T04:27:56Z","timestamp":1683692876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-023-00512-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1186\/s13293-023-00512-z","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study can be found in both the Netherlands National Trial Register (NTR; ) and the WHO International Clinical Trials Registry Platform (ICTRP; ) with the catalogue number NTR6831. All participants provided written informed consent according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}